Primary cardiac Burkitt lymphoma can present with tamponade physiology and be successfully treated with modified CODOX-M/IVAC and rituximab, achieving long-term remission.
May support modified CODOX-M/IVAC plus rituximab in rare primary cardiac Burkitt lymphoma; leaves open optimal regimen and generalizability.
We describe the case of a 44-year-old woman with primary Burkitt lymphoma of the heart who presented with abdominal bloating and epigastric discomfort secondary to tamponade physiology caused by a large pericardial effusion. The pericardial fluid contained a large number of highly atypical lymphocytes with moderate basophilic cytoplasm, rare punched-out vacuoles, a vesicular nuclear chromatin, large nucleolus, and marginated chromatin that by FISH were positive for the 8;14 translocation. She had no other sites of disease. She was treated with four alternating cycles of modified CODOX-M and IVAC in combination with rituximab and remains in remission more than 5 years since diagnosis.
No takes yet. Share an insight, caveat, or question.
Tzachanis et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: